(REGISTER CLOSED) 58th Breakfast Meeting: Recent Developments in Health Technology Assessments (tentative title)
date : 5/9/2016
Please note that this event will be held only in Japanese
■Speraker:
Dr. Ataru Igarashi
(Assistant Professor at The University of Tokyo’s Graduate School of Pharmaceutical Sciences)
■Date & Time:
Thursday, Jun 2, 2016 8:00-9:15am (Doors open 7:45am)
■Venue:
EGG JAPAN
(10th floor, Shin-Marunouchi Building, 1-5-1 Marunouchi, Chiyoda-ku, Tokyo)
■Participation fee:
General: 2,500 JPN Yen
Students: 1,500 JPN Yen for students (Student ID required)
Individual supporting members: Free
■Summary:
There has recently been more and more movement toward the introduction of Health Technology Assessments (HTA) to the health care policy making process in light of increased healthcare costs. In Japan, a trial introduction of cost-effectiveness evaluations within the drug and medical device approval process was started following the FY2016 Revision of Medical Fee.
In order to construct a sustainable health care system that meets global standards, Japan must utilize the limited resources available to it as efficiently and effectively as possible and maximize the value attainable from healthcare services. At the next Breakfast Meeting, Dr. Ataru Igarashi, one of the few HTA professionals in Japan, will join us to explain what HTA is, how it evaluates the value of medicine, and how HTA outcomes can be reflected in policies, with examples from recent HTA use cases.
■Keywords:
Pharmacoeconomics, Health Economics Evaluation, Cost-effectiveness Evaluation, QALY (Quality Adjusted Life years), QOL (Quality of Life)
■About Dr. Igarashi:
Dr. Igarashi received his Ph.D. (Pharmacoeconomics/Pharmaceutical Economics) from the Endowed Laboratory of Drug Policy and Management in the Graduate School of Pharmaceutical Sciences of the University of Tokyo (2008). He is Co-President of the Health Outcome Research Institute (2010 – Present). He specializes in biostatistics, health economics, and pharmacoeconomics.
■ Reference book:
・‘What is Pharmacoeconomics?’ (Authors: Ataru Igarashi, Mari Sato)
http://goo.gl/pnXuCD
・Nikkei Medical Online Series ‘I can’t quite understand what Pharmacoeconomics is’ by Ataru Igarashi”
http://medical.nikkeibp.co.jp/inc/all/series/yakuzaikeizai/
*Registration will close at 23:59 pm on May 22. Participants will be selected by lot and will be informed of the result by the end of May 24. We appreciate your understanding.
**Please inform us if you would like to cancel by 17:00, May 30. If you cancel after this, participation fee might incur.
Registration deadline: 2016-05-22
Exhibition date:2016-06-02
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Three Necessary Perspectives for Formulating the Basic Plan for the Promotion of Policies on Dementia: Creating a Society That is Inclusive for All People at All Times (April 1, 2024)
- [Policy Recommendations] Establishing an integrated care system for pain from the perspectives of people with lived experience (March 29, 2024)
Featured Posts
-
2024-04-02
[Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
-
2024-04-08
[Event Report] HGPI Participates in the Connecting Climate Minds Global Event (March 19-21, 2024)
-
2024-04-08
[Registration Open] The 124th HGPI Seminar “Reconsidering Infectious Disease Control Strategies Centering on Vaccination and Immunization – From the Experiences of the COVID-19 Pandemic and a Life Course Approach” (April 26, 2024)
-
2024-04-10
[Research Report] “International comparison of dementia policies, research study on information dissemination.” (April 10, 2024)
-
2024-04-11
[Research Paper] “Exploring the Potential of Industry-Academia-Civil Collaboration for Sustainability in the Healthcare Sector” Published in Journal Society for Environmental Economics and Policy Studies (March 31, 2024)